InvestorsHub Logo
Followers 30
Posts 3486
Boards Moderated 0
Alias Born 12/05/2021

Re: Lykiri post# 428128

Tuesday, 12/21/2021 10:16:22 AM

Tuesday, December 21, 2021 10:16:22 AM

Post# of 730048
The MHRA license approval enables the manufacturing of DCVax-L products to get under way at the Sawston facility in addition to continuing at the smaller GMP facility in London. The license also permits the import and GMP manufacture of other cell therapy products under the UK's supply of unlicensed medicinal products ('Specials') regime and for clinical trials under the Investigational Medicinal Products (IMP) Programme.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News